[O:1]=[C:2]1[CH2:7][CH2:6][N:5]([C:8]([O:10][C:11]([CH3:14])([CH3:13])[CH3:12])=[O:9])[CH2:4][CH2:3]1.[CH:15]1([CH2:20][C:21](Cl)=[O:22])[CH2:19][CH2:18][CH2:17][CH2:16]1>>[CH:15]1([CH2:20][C:21]([CH:7]2[C:2](=[O:1])[CH2:3][CH2:4][N:5]([C:8]([O:10][C:11]([CH3:14])([CH3:13])[CH3:12])=[O:9])[CH2:6]2)=[O:22])[CH2:19][CH2:18][CH2:17][CH2:16]1tert-Butyl 3-(2-cyclopentylacetyl)-4-oxopiperidine-1-carboxylate (311 mg, 59%) was synthesised from tert-butyl 4-oxopiperidine-1-carboxylate and 2-cyclopentylacetyl chloride according to the general procedure for the preparation of diketones. MS (ES−) m/z 308.1 (M−H)−